A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Dr. Jeffrey Carlson Performed the 1st Implantation of a Boston Scientific WaveWriter Alpha ImageReady™ MRI Compatible Spinal Cord Stimulator on the Peninsula

March 10. 2021

Dr. Jeffrey R. Carlson performed the outpatient surgery on a 62-year-old female at Coastal Virginia Surgery Center in Newport News, VA, on March 3, 2021.

The patient, who had previously experienced years of chronic pain in the lumbar spine, was able to walk, climb stairs, and be discharged 30 minutes after the procedure. In a follow-up call with the patient the next day, she expressed relief from her chronic pain.

This exciting technology is available for patients suffering from chronic pain where alternative therapies have not been successful. Interested patients may try the stimulator for one week with a temporary device implanted in OSC’s Interventional Pain Management Specialists’ office. Patients help direct the stimulation toward the pain area during implantation and may choose to feel a sensation, such as bubbling or feeling nothing at all.

“Spinal cord stimulators have made significant improvements in patients’ pain and are becoming more easily adjusted,” explained Dr. Jeffrey R. Carlson, Orthopaedic Surgeon and President and Managing Partner of Orthopaedic and Spine Center. “This new stimulator allows patients to remove the last real complaint patients have about the device, the inability to get an MRI after it is implanted. MRI aides in many diagnoses, so this innovation allows patients to have the necessary diagnostic tests for any condition requiring an MRI.”

OSC offers orthopedic, sports medicine, spine care, and a dedicated Interventional Pain Management Team, including two interventional pain management physicians and one pain psychologist who are dedicated to identifying and treating chronic pain disorders. Using minimally invasive treatment options and physical therapy, over 90 percent of our patients recover without surgery. The Team is rounded out with a pain psychologist to help patients live their best life despite chronic pain.

“We are thrilled to assist our patients in enjoying the lifestyle they want and deserve,” says Dr. Boyd W. Haynes III, President of Coastal Virginia Surgery Center. “Helping them to overcome chronic pain allows our patients to get back to the life they love. Procedures, such as this, can be safely performed in an outpatient surgical center setting allowing them to recover where they’d prefer, at home, with follow-up care.”

Coastal Virginia Surgery Center (CVSC) offers a wide range of outpatient surgery options, boasting seven orthopedic surgeons and two interventional pain management specialists. Surgery centers provide less exposure to serious infections and a high-level of care at a lower cost to both the patient and insurance company.

OSC physicians are accepting new patients, and CVSC is scheduling surgeries, both with additional precautions during the COVID-19 Pandemic.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy